R. Cornelissen, M. Heuvers, and A. Maat, New Roads Open Up for Implementing Immunotherapy in Mesothelioma, Clinical and Developmental Immunology, vol.180, issue.3, p.927240, 2012.
DOI : 10.4049/jimmunol.0803826

S. Biswas and A. Mantovani, Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, Nature Immunology, vol.313, issue.10, pp.889-896, 2010.
DOI : 10.1016/j.ccr.2009.06.017

A. Mantovani, S. Sozzani, and M. Locati, Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes, Trends in Immunology, vol.23, issue.11, pp.549-555, 2002.
DOI : 10.1016/S1471-4906(02)02302-5

F. Martinez, L. Helming, and S. Gordon, Alternative Activation of Macrophages: An Immunologic Functional Perspective, Annual Review of Immunology, vol.27, issue.1, pp.451-483, 2009.
DOI : 10.1146/annurev.immunol.021908.132532

X. Tang, C. Mo, and Y. Wang, Anti-tumour strategies aiming to target tumour-associated macrophages, Immunology, vol.331, issue.Suppl 1, pp.93-104, 2013.
DOI : 10.1111/imm.12023

B. Burt, S. Rodig, and T. Tilleman, Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma, Cancer, vol.205, issue.14 suppl, pp.5234-5244, 2011.
DOI : 10.1002/cncr.26143

R. Cornelissen, L. Lievense, and A. Maat, Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma, PLoS ONE, vol.44, issue.9, p.106742, 2014.
DOI : 10.1371/journal.pone.0106742.t002

R. Cornelissen, L. Lievense, and J. Robertus, Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma, Lung Cancer, vol.88, issue.3, pp.332-337, 2015.
DOI : 10.1016/j.lungcan.2015.03.013

I. Conti and B. Rollins, CCL2 (monocyte chemoattractant protein-1) and cancer, Seminars in Cancer Biology, vol.14, issue.3, pp.149-154, 2004.
DOI : 10.1016/j.semcancer.2003.10.009

L. Borsig, M. Wolf, and M. Roblek, Inflammatory chemokines and metastasis???tracing the accessory, Oncogene, vol.11, issue.25, pp.3217-3224, 2014.
DOI : 10.1016/j.yexcr.2010.12.021

F. Gueugnon, S. Leclercq, and C. Blanquart, Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma, The American Journal of Pathology, vol.178, issue.3, pp.1033-1042, 2011.
DOI : 10.1016/j.ajpath.2010.12.014

C. Blanquart, F. Gueugnon, and J. Nguyen, CCL2, Galectin-3, and SMRP Combination Improves the Diagnosis of Mesothelioma in Pleural Effusions, Journal of Thoracic Oncology, vol.7, issue.5, pp.883-889, 2012.
DOI : 10.1097/JTO.0b013e31824c9272

A. Sica, T. Schioppa, and A. Mantovani, Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy, European Journal of Cancer, vol.42, issue.6, pp.717-727, 2006.
DOI : 10.1016/j.ejca.2006.01.003

M. Cioce, C. Canino, and C. Goparaju, Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation, Cell Death and Disease, vol.17, issue.4, p.1167, 2014.
DOI : 10.1128/MCB.20.4.1436-1447.2000

A. Dudek, H. Pang, and R. Kratzke, Phase II Study of Dasatinib in Patients with Previously Treated Malignant Mesothelioma (Cancer and Leukemia Group B 30601): A Brief Report, Journal of Thoracic Oncology, vol.7, issue.4, pp.755-759, 2012.
DOI : 10.1097/JTO.0b013e318248242c

H. Ide, K. Hatake, and Y. Terado, Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis, Human Cell, vol.60, issue.1, pp.1-6, 2008.
DOI : 10.1111/j.1749-0774.2007.00042.x

J. Kaminska, M. Kowalska, and B. Kotowicz, Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis, Oncology, vol.70, issue.2, pp.115-125, 2006.
DOI : 10.1159/000093002

M. Kowalska, J. Tajer, and M. Chechlinska, Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma, Medical Oncology, vol.206, issue.3, pp.2143-2147, 2012.
DOI : 10.1007/s12032-011-0010-1

B. Mroczko, M. Groblewska, and U. Wereszczynska-siemiatkowska, Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis, Clinica Chimica Acta, vol.380, issue.1-2, pp.208-212, 2007.
DOI : 10.1016/j.cca.2007.02.037

D. Lacey, A. Achuthan, and A. Fleetwood, Defining GM-CSF- and Macrophage-CSF-Dependent Macrophage Responses by In Vitro Models, The Journal of Immunology, vol.188, issue.11, pp.5752-5765, 2012.
DOI : 10.4049/jimmunol.1103426

A. Sica, P. Larghi, and A. Mancino, Macrophage polarization in tumour progression, Seminars in Cancer Biology, vol.18, issue.5, pp.349-355, 2008.
DOI : 10.1016/j.semcancer.2008.03.004

L. Peng, S. Shu, and J. Krauss, Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells, Cancer Res, vol.57, pp.4849-4854, 1997.

P. Vitiello, M. Shainheit, and E. Allison, Impact of tumor-derived CCL2 on T cell effector function, Immunology Letters, vol.91, issue.2-3, pp.239-245, 2004.
DOI : 10.1016/j.imlet.2003.12.009

Z. Fridlender, G. Buchlis, and V. Kapoor, CCL2 Blockade Augments Cancer Immunotherapy, Cancer Research, vol.70, issue.1, pp.109-118, 2010.
DOI : 10.1158/0008-5472.CAN-09-2326

Z. Fridlender, V. Kapoor, and G. Buchlis, Cells, American Journal of Respiratory Cell and Molecular Biology, vol.44, issue.2, pp.230-237, 2011.
DOI : 10.1165/rcmb.2010-0080OC

M. Ryder, M. Gild, and T. Hohl, Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression, PLoS ONE, vol.18, issue.1, p.54302, 2013.
DOI : 10.1371/journal.pone.0054302.s006

E. Sloan, S. Priceman, and B. Cox, The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer, Cancer Research, vol.70, issue.18, pp.7042-7052, 2010.
DOI : 10.1158/0008-5472.CAN-10-0522

N. Weizman, Y. Krelin, and A. Shabtay-orbach, Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase, Oncogene, vol.46, issue.29, pp.3812-3819, 2014.
DOI : 10.1038/nature11249